Teva Sues Generics To Protect Huntington's Disease Drug
Teva Pharmaceuticals has filed patent infringement suits in New Jersey to stop two India-based generics companies from releasing drugs the company says would compete with its own branded breakthrough treatment for...To view the full article, register now.
Already a subscriber? Click here to view full article